A systematic review of the limitations and approaches to improve detection and management of peripheral arterial disease in Hispanics

Journal of Vascular Surgery

Volumn 51, Issue 4 SUPPL., 2010, Pages

  Rosero, Eric B ^a   Kane, Katherine ^a   Clagett, G Patrick ^a   Timaran, Carlos H ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; ANTITHROMBOCYTIC AGENT; CHOLESTEROL; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINE;

ARTERY CALCIFICATION; ARTERY DISEASE; CLINICAL EXAMINATION; COMMUNITY CARE; COMORBIDITY; DIABETES MELLITUS; EARLY DIAGNOSIS; ENDOVASCULAR SURGERY; ETHNIC DIFFERENCE; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HISPANIC; HUMAN; KINESIOTHERAPY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; PULSE WAVE; RACE DIFFERENCE; REVASCULARIZATION; REVIEW; RISK FACTOR; RISK REDUCTION; SMOKING; SMOKING CESSATION; SYSTEMATIC REVIEW; UNITED STATES;

CARDIOVASCULAR DISEASES; COMMUNITY HEALTH SERVICES; CULTURAL CHARACTERISTICS; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE PROGRESSION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 77949772073     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.08.085     Document Type: Review

References (85)

1. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31 (2000) S1-S296
2. Criqui M.H., Fronek A., Barrett-Connor E., Klauber M.R., Gabriel S., and Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 71 (1985) 510-515
3. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
4. McDermott M.M., Kerwin D.R., Liu K., Martin G.J., O'Brien E., Kaplan H., et al. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice*. J Gen Intern Med 16 (2001) 384-390
5. Fowkes F.G., Housley E., Cawood E.H., Macintyre C.C., Ruckley C.V., and Prescott R.J. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20 (1991) 384-392
6. Meijer W.T., Hoes A.W., Rutgers D., Bots M.L., Hofman A., and Grobbee D.E. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 18 (1998) 185-192
7. Newman A.B., Sutton-Tyrrell K., Vogt M.T., and Kuller L.H. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 270 (1993) 487-489
8. Golomb B.A., Dang T.T., and Criqui M.H. Peripheral arterial disease: morbidity and mortality implications. Circulation 114 (2006) 688-699
9. Hirsch A.T., Gloviczki P., Drooz A., Lovell M., and Creager M.A. Mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health. J Vasc Surg 39 (2004) 474-481
10. Khaira H.S., Hanger R., and Shearman C.P. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg 11 (1996) 65-69
11. McDermott M.M., Greenland P., Liu K., Guralnik J.M., Criqui M.H., Dolan N.C., et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 286 (2001) 1599-1606
12. McDermott M.M., Hoff F., Ferrucci L., Pearce W.H., Guralnik J.M., Tian L., et al. Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease. J Am Geriatr Soc 55 (2007) 400-406
13. Diehm C., Schuster A., Allenberg J.R., Darius H., Haberl R., Lange S., et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172 (2004) 95-105
14. Murabito J.M., Evans J.C., Nieto K., Larson M.G., Levy D., and Wilson P.W. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 143 (2002) 961-965
15. Regensteiner J.G., and Hiatt W.R. Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med 112 (2002) 49-57
16. Collins T.C., Petersen N.J., Suarez-Almazor M., and Ashton C.M. Ethnicity and peripheral arterial disease. Mayo Clin Proc 80 (2005) 48-54
17. Criqui M.H., Vargas V., Denenberg J.O., Ho E., Allison M., Langer R.D., et al. Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation 112 (2005) 2703-2707
18. McDermott M.M., Liu K., Criqui M.H., Ruth K., Goff D., Saad M.F., et al. Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol 162 (2005) 33-41
19. Premalatha G., Shanthirani S., Deepa R., Markovitz J., and Mohan V. Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: the Chennai Urban Population Study. Diabetes Care 23 (2000) 1295-1300
20. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
21. US Census Bureau. US Interim Projections by Age, Sex, Race, and Hispanic Origin. http://www.census.gov/ipc/www/usinterimproj Accessed Apr 1, 2009
22. Healthy People 2010 Goals. http://www.healthypeople.gov/About/goals.htm Accessed Apr 11, 2007
23. NIH. Addressing Health Disparities: The NIH Program of Action. http://healthdisparities.nih.gov/whatare.html Accessed Apr 24, 2007
24. Haffner S.M., Hazuda H.P., Mitchell B.D., Patterson J.K., and Stern M.P. Increased incidence of type II diabetes-mellitus in Mexican-Americans. Diabetes Care 14 (1991) 102-108
25. Criqui M.H., Allison M.A., McDermott M.M., Liu K., Bertoni A.G., Folsom A., et al. Ethnic differences and risk factors for peripheral arterial disease (PAD) in the multi-ethnic study of atherosclerosis (MESA). Circulation 109 (2004) E78
26. Allison M.A., Criqui M.H., McClelland R.L., Scott J.M., McDermott M.M., Liu K., et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 48 (2006) 1190-1197
27. Fowkes F.G. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol 17 (1988) 248-254
28. Lijmer J.G., Hunink M.G., van den Dungen J.J., Loonstra J., and Smit A.J. ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol 22 (1996) 391-398
29. Aboyans V., Ho E., Denenberg J.O., Ho L.A., Natarajan L., and Criqui M.H. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg 48 (2008) 1197-1203
30. Doobay A.V., and Anand S.S. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 25 (2005) 1463-1469
31. McDermott M.M., Guralnik J.M., Tian L., Liu K., Ferrucci L., Liao Y., et al. Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol 53 (2009) 1056-1062
32. Wang J.C., Criqui M.H., Denenberg J.O., McDermott M.M., Golomb B.A., and Fronek A. Exertional leg pain in patients with and without peripheral arterial disease. Circulation 112 (2005) 3501-3508
33. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113 (2006) e463-e654
34. Stein R., Hriljac I., Halperin J.L., Gustavson S.M., Teodorescu V., and Olin J.W. Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease. Vasc Med 11 (2006) 29-33
35. Taguchi J.T., and Suwangool P. "Pipe-stem" brachial arteries. A cause of pseudohypertension. JAMA 228 (1974) 733
36. Ramsey D.E., Manke D.A., and Sumner D.S. Toe blood pressure. A valuable adjunct to ankle pressure measurement for assessing peripheral arterial disease. J Cardiovasc Surg (Torino) 24 (1983) 43-48
37. Carter S.A., and Tate R.B. The value of toe pulse waves in determination of risks for limb amputation and death in patients with peripheral arterial disease and skin ulcers or gangrene. J Vasc Surg 33 (2001) 708-714
38. Aboyans V., Criqui M.H., McClelland R.L., Allison M.A., McDermott M.M., Goff Jr. D.C., et al. Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA). J Vasc Surg 45 (2007) 319-327
39. Suominen V., Rantanen T., Venermo M., Saarinen J., and Salenius J. Prevalence and risk factors of PAD among patients with elevated ABI. Eur J Vasc Endovasc Surg 35 (2008) 709-714
40. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K., et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119 (2009) 480-486
41. McBean A.M., Li S., Gilbertson D.T., and Collins A.J. Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, Hispanics, and Asians. Diabetes Care 27 (2004) 2317-2324
42. Narayan K.M., Boyle J.P., Geiss L.S., Saaddine J.B., and Thompson T.J. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 29 (2006) 2114-2116
43. Symes J.F., Graham A.M., and Mousseau M. Doppler waveform analysis versus segmental pressure and pulse-volume recording: assessment of occlusive disease in the lower extremity. Can J Surg 27 (1984) 345-347
44. Teodorescu V.J., Chen C., Morrissey N., Faries P.L., Marin M.L., and Hollier L.H. Detailed protocol of ischemia and the use of noninvasive vascular laboratory testing in diabetic foot ulcers. Am J Surg 187 (2004) 75S-80S
45. Aboyans V., Criqui M.H., Denenberg J.O., Knoke J.D., Ridker P.M., and Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 113 (2006) 2623-2629
46. Collins T.C., Petersen N.J., Suarez-Almazor M., and Ashton C.M. The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med 163 (2003) 1469-1474
47. Lepor N.E., and Vogel R.E. Summary of the third report of the National Cholesterol Education Program Adult Treatment Panel III. Rev Cardiovasc Med 2 (2001) 160-165
48. Steg P.G., Bhatt D.L., Wilson P.W., D'Agostino Sr. R., Ohman E.M., Rother J., et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 297 (2007) 1197-1206
49. Belch J.J., Topol E.J., Agnelli G., Bertrand M., Califf R.M., Clement D.L., et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163 (2003) 884-892
50. Diehm C., Lange S., Darius H., Pittrow D., von S.B., Tepohl G., et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 27 (2006) 1743-1749
51. Leng G.C., Fowler B., and Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2 (2000) CD000990
52. Gardner A.W., and Poehlman E.T. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 274 (1995) 975-980
53. Garg P.K., Liu K., Tian L., Guralnik J.M., Ferrucci L., Criqui M.H., et al. Physical activity during daily life and functional decline in peripheral arterial disease. Circulation 119 (2009) 251-260
54. Currie I.C., Wilson Y.G., Baird R.N., and Lamont P.M. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg 10 (1995) 356-361
55. Regensteiner J.G., Meyer T.J., Krupski W.C., Cranford L.S., and Hiatt W.R. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology 48 (1997) 291-300
56. Shephard R.J., and Balady G.J. Exercise as cardiovascular therapy. Circulation 99 (1999) 963-972
57. Health, United States, 2008 with Chartbook (2009), National Center for Health Statistics, Hyattsville, MD
58. Hankey G.J., Norman P.E., and Eikelboom J.W. Medical treatment of peripheral arterial disease. JAMA 295 (2006) 547-553
59. Mohler III E.R., Hiatt W.R., and Creager M.A. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation 108 (2003) 1481-1486
60. Mondillo S., Ballo P., Barbati R., Guerrini F., Ammaturo T., Agricola E., et al. Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med 114 (2003) 359-364
61. McDermott M.M., Guralnik J.M., Greenland P., Pearce W.H., Criqui M.H., Liu K., et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation 107 (2003) 757-761
62. Nelson K., Norris K., and Mangione C.M. Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 162 (2002) 929-935
63. Stern M.P., Patterson J.K., Haffner S.M., Hazuda H.P., and Mitchell B.D. Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey. JAMA 262 (1989) 360-364
64. Giles W.H., Anda R.F., Jones D.H., Serdula M.K., Merritt R.K., and DeStefano F. Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities. JAMA 269 (1993) 1133-1138
65. Feinglass J., McCarthy W.J., Slavensky R., Manheim L.M., and Martin G.J. Functional status and walking ability after lower extremity bypass grafting or angioplasty for intermittent claudication: results from a prospective outcomes study. J Vasc Surg 31 (2000) 93-103
66. Kalbaugh C.A., Taylor S.M., Blackhurst D.W., Dellinger M.B., Trent E.A., and Youkey J.R. One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease. J Vasc Surg 44 (2006) 296-302
67. Singh N., Sidawy A.N., DeZee K.J., Neville R.F., Akbari C., and Henderson W. Factors associated with early failure of infrainguinal lower extremity arterial bypass. J Vasc Surg 47 (2008) 556-561
68. Feinglass J., Rucker-Whitaker C., Lindquist L., McCarthy W.J., and Pearce W.H. Racial differences in primary and repeat lower extremity amputation: results from a multihospital study. J Vasc Surg 41 (2005) 823-829
69. Kwolek C.J., and Clagett G.P. Changing demographics in patients with vascular disease. J Vasc Surg 49 (2009) 528-531
70. Rowe V.L., Kumar S.R., Glass H., Hood D.B., and Weaver F.A. Race independently impacts outcome of infrapopliteal bypass for symptomatic arterial insufficiency. Vasc Endovascular Surg 41 (2007) 397-401
71. Morrissey N.J., Giacovelli J., Egorova N., Gelijns A., Moskowitz A., McKinsey J., et al. Disparities in the treatment and outcomes of vascular disease in Hispanic patients. J Vasc Surg 46 (2007) 971-978
72. Robinson III W.P., and Owens C.D. Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage. J Vasc Surg 49 (2009) 1416-1425
73. Baicker K, Chandra A, Skinner JS, Wennberg JE. Who you are and where you live: how race and geography affect the treatment of medicare beneficiaries. Health Aff (Millwood) 2004;Suppl Web Exclusives:VAR33-VAR44.
74. Chandra A. Who you are and where you live: race and the geography of healthcare. Med Care 47 (2009) 135-137
75. MacQueen K.M., McLellan E., Metzger D.S., Kegeles S., Strauss R.P., Scotti R., et al. What is community?. An evidence-based definition for participatory public health. Am J Public Health 91 (2001) 1929-1938
76. Community-Based Participatory Research. http://www.ahrq.gov/about/cpcr/cbpr Accessed April 1, 2007
77. Israel B.A., Schulz A.J., Parker E.A., and Becker A.B. Community-based participatory research: policy recommendations for promoting a partnership approach in health research. Educ Health (Abingdon) 14 (2001) 182-197
78. Corkery E., Palmer C., Foley M.E., Schechter C.B., Frisher L., and Roman S.H. Effect of a bicultural community health worker on completion of diabetes education in a Hispanic population. Diabetes Care 20 (1997) 254-257
79. Elder J.P., Ayala G.X., Campbell N.R., Slymen D., Lopez-Madurga E.T., Engelberg M., et al. Interpersonal and print nutrition communication for a Spanish-dominant Latino population: Secretos de la Buena Vida. Health Psychol 24 (2005) 49-57
80. Hunter J.B., de Zapien J.G., Papenfuss M., Fernandez M.L., Meister J., and Giuliano A.R. The impact of a promotora on increasing routine chronic disease prevention among women aged 40 and older at the U.S.-Mexico border. Health Educ Behav 31 (2004) 18S-28S
81. Hill M.N., Han H.R., Dennison C.R., Kim M.T., Roary M.C., Blumenthal R.S., et al. Hypertension care and control in underserved urban African American men: behavioral and physiologic outcomes at 36 months. Am J Hypertens 16 (2003) 906-913
82. Becker D.M., Yanek L.R., Johnson Jr. W.R., Garrett D., Moy T.F., Reynolds S.S., et al. Impact of a community-based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease. Circulation 111 (2005) 1298-1304
83. Gary T.L., Bone L.R., Hill M.N., Levine D.M., McGuire M., Saudek C., et al. Randomized controlled trial of the effects of nurse case manager and community health worker interventions on risk factors for diabetes-related complications in urban African Americans. Prev Med 37 (2003) 23-32
84. Balcazar H., Alvarado M., Cantu F., Pedregon V., and Fulwood R. A promotora de salud model for addressing cardiovascular disease risk factors in the US-Mexico border region. Prev Chronic Dis 6 (2009) A02
85. Artinian N.T., Schim S.M., Vander Wal J.S., and Nies M.A. Eating patterns and cardiovascular disease risk in a Detroit Mexican American population. Public Health Nurs 21 (2004) 425-434